Pfizer & Co., Inc.

Overview

  • Founded Date April 20, 1984
  • Sectors Health
  • Posted Jobs 0
  • Viewed 4

Company Description

Erectile Dysfunction Drugs could Assist Treat Oesophageal Cancer, Study Finds

Erectile dysfunction drugs could help treat oesophageal cancer, study finds

22 June 2022

An active ingredient in impotence medication might assist deal with oesophageal cancer, a research study has discovered.

Southampton scientists discovered the PDE5 inhibitors in the medication helped penetrate the barrier of cells around tumours, allowing chemotherapy drugs to reach cancer cells.

One in 10 patients presently survives the illness, which is found anywhere in the gullet, for 10 years or more.

The study was funded by Cancer Research UK. The next phase is a medical trial.

Prof Tim Underwood, lead author of the research study, said the discovery might enhance these survival rates.

He said a cell called the cancer-associated fibroblast, responsible for injury healing, could be targeted with the inhibitors.

“It’s been utilized throughout the world in countless dosages,” he explained. “It’s safe, and we used it to cancer.”

He added it was to the researchers “wonder and surprise and delight” that the drug had an impact.

“We need to put this into a scientific trial where we try the drug type together with chemotherapy to see if it makes the chemotherapy more efficient,” he said.

“The initial work suggests it must do, and if it does and if it’s safe, and it improves results of chemotherapy, then it might be actually substantial for the patients I look after.”

The research study was carried out utilizing tumours from eight cancer patients, with additional tests done on mice.

Chemotherapy just helps 20% of oesophageal cancer patients in a substantial method, he stated.

“If this drug mix even enhances it by a small amount, we’re actually going to assist a large number of individuals every year to react better and live longer.”

Researchers at Hospitals state that the typical results of erectile dysfunction condition drugs require additional stimulation, so would not affect cancer patients in the very same way.

Prof Underwood stated the primary side effects would be “a little bit of headache, a little flushing”.

Terry Daly, from Aldershot, Hampshire, is among the 9,500 people identified with oesophageal cancer in the UK every year.

It frequently goes unnoticed in the early stages, with Mr Daly finding it was hard to swallow his food and he ended up regurgitating it.

He is shortly to go through another round of chemotherapy, and stated if he had the option to take the new treatment he would have “taken it with both hands”.

“The research study that is being done is definitely wonderful,” he stated.

“It is just extraordinary that there are individuals out there ready to spend their lives simply attempting to find a cure, so that people can proceed with their daily lives and not need to go through all this stuff.

“You can’t thank these individuals enough for what they’re doing.”

The five-year research study has actually been moneyed by Cancer Research UK and the Medical Research Council.

A medical trial is anticipated within the next 18 months and if effective, it is hoped new treatments based upon this research study could be used within ten years.

Follow BBC South on Facebook, external, Twitter, external, or Instagram, external. Send your story concepts to south.newsonline@bbc.co.uk, external.

Related subjects

Aldershot

Southampton

Cancer

We had the very same cancer as Andy Goram

31 May 2022

Lorry driver’s ‘ticking time-bomb’ cancer gene

20 June 2022

Related web links

Cancer Research UK

University Hospital Southampton

Institute of Developmental Sciences – University of Southampton

What is oesophageal cancer? – NHS

The BBC is not responsible for the material of external sites.

Scroll to Top